List of insiders holdings for Aimmune Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Societe des Produits Nestle S.A. 10% Owner |
2020-10-15 19:18:28 | 13,252,747 23,408,817 |
36,661,564 | Form 4 |
| 2 | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
2020-02-12 16:24:37 | 6,215,278 0 |
6,215,278 | Form 13G |
| 3 | Tammenoms Bakker Juliet 10% Owner |
2018-02-26 16:25:25 | 16,651 6,013,134 |
6,029,785 | Form 4 |
| 4 | DILLY STEPHEN GEORGE President and CEO |
2018-06-13 16:06:33 | 611,250 131,700 |
742,950 | Form 4 |
| 5 | Raff Howard V. Chief Operating Officer |
2015-08-05 18:41:49 | 98,775 428,575 |
527,350 | Form 3 |
| 6 | Elfont Robert Myles Chief Medical Officer |
2016-02-26 19:35:27 | 379,002 0 |
379,002 | Form 4 |
| 7 | DeSouza Warren L. Chief Financial Officer |
2017-04-05 16:05:35 | 324,475 0 |
324,475 | Form 4 |
| 8 | Knapp Jeffrey H Chief Operating Officer |
2018-03-06 20:42:30 | 68,401 0 |
68,401 | Form 4 |
| 9 | Barrowcliffe Susan E. General Manager, Europe |
2018-11-21 16:05:54 | 62,775 0 |
62,775 | Form 4 |
| 10 | Rozenman Mary M. See Remarks |
2020-02-14 17:23:52 | 13,878 0 |
13,878 | Form 5 |
| 11 | Behar Gregory Director |
2020-10-14 16:15:28 | 10,192 0 |
10,192 | Form 4 |
| 12 | Nestle Health Science US Holdings Inc. Societe des Produits Nestle S.A. NESTLE SA NIMCO US Inc. Nestle US Holdco Inc. 10% Owner |
2020-10-13 10:48:59 | 100 0 |
100 | Form 13D |
| 13 | Societe des Produits Nestle S.A. NESTLE SA 10% Owner |
2020-10-13 10:48:59 | 100 0 |
100 | Form 13D |
| 14 | Foresite Capital Management II LLC Foresite Capital Fund II L.P. Foresite Capital Management III LLC Foresite Capital Fund III L.P. Tananbaum James B. 10% Owner |
2020-02-13 21:20:20 | 0 0 |
0 | Form 13G |
| 15 | Oxtoby Andrew Chief Commercial Officer |
2020-10-14 16:15:36 | 0 0 |
0 | Form 4 |
| 16 | Sheehy Douglas T. See Remarks |
2020-10-14 16:15:34 | 0 0 |
0 | Form 4 |
| 17 | Dallas Jayson Donald Alexander President and CEO |
2020-10-14 16:15:31 | 0 0 |
0 | Form 4 |
| 18 | MCDADE MARK Director |
2020-10-14 16:15:30 | 0 0 |
0 | Form 4 |
| 19 | HAUMANN BRETT K Director |
2020-10-14 16:15:24 | 0 0 |
0 | Form 4 |
| 20 | Seltzer Stacey Denenberg Director |
2020-10-14 16:15:23 | 0 0 |
0 | Form 4 |
| 21 | BJERKHOLT ERIC Chief Financial Officer |
2020-10-14 16:15:18 | 0 0 |
0 | Form 4 |
| 22 | Iwicki Mark T Director |
2020-10-14 16:15:14 | 0 0 |
0 | Form 4 |
| 23 | ENRIGHT PATRICK G Director |
2020-10-14 16:15:14 | 0 0 |
0 | Form 4 |
| 24 | FALBERG KATHRYN E Director |
2020-10-14 16:15:10 | 0 0 |
0 | Form 4 |
| 25 | ADELMAN DANIEL C MD Chief Medical Officer |
2020-10-14 16:15:11 | 0 0 |
0 | Form 4 |